Transcript
A (0:05)
A big day for trade reporters, huh?
B (0:08)
Yes, one of many, but maybe this is the biggest one so far.
A (0:13)
Today, the Supreme Court ruled that the majority of President Trump's tariffs are illegal. Our colleague Gavin Bate has been following Trump's tariffs since the get go.
B (0:24)
He has used emergency economic authority under a novel use of an emergency law to institute most of his tariffs. And today, the Supreme Court said that he overstepped his bounds, that this should be a congressional authority, and that most of his tariffs were illegal. So raises a lot of questions for both the administration and, you know, the law firms here in Washington.
A (0:46)
Right. And for the US Economy, quite frankly.
B (0:48)
Yes, absolutely. You know, there are many, many answers that still, you know, in the hours after this decision are still unknown. But what we know now is that he overstepped his bounds in instituting a lot of these levies and is going to have to go back to the drawing on many of them.
A (1:05)
Trump has justified the bulk of his tariff policy using a 1977 law called the International Emergency Economic Powers act, known as ia.
B (1:14)
When you see him threatening tariffs at the drop of a hat, this is the legal authority he's using because it's the most flexible and it allows him to just instantaneously, with a presidential proclamation, change the tariff code. The Supreme Court today said, you can't do that. That is not an appropriate use of this law. You're going to have to come up with another legal justification for these tariff.
A (1:40)
How big of a setback is this for Trump's economic agenda?
B (1:44)
I think it's a big setback. So he's going to have to, you know, recalibrate his approach to economic diplomacy here.
A (1:54)
Welcome to the Journal, our show about money, business and power. I'm Ryan knudsen. It's Friday, February 20th. Up on the show, the Supreme Court says Trump's global tariffs are illegal. But Trump is not backing down.
C (2:23)
For adults with Crohn's disease or ulcerative colitis symptoms, every choice matters. Tremphya offers self injection or intravenous infusion. From the start. Tremphya is administered as injections under the skin or infusions through a vein every four weeks, followed by injections under the skin every four or eight weeks. If your doctor decides that you can self inject Tremphya, proper training is required. Tremphya is a prescription medicine used to treat adults with moderately to severely active Crohn's disease and adults with moderately to severely active ulcerative colitis. Serious allergic reactions and increased risk of infections and liver problems may occur before treatment, your doctor should check you for infections and tuberculosis. Tell your doctor if you have an infection, flu like symptoms, or if you need a vaccine. Explore what's possible. Ask your doctor about tremphya today. Call 1-800-526-7736 to learn more or visit tremphyaradio.com.
